Spok Holdings, Inc. (SPOK) P/E Ratio History
UndervaluedTrading at 14.0x vs 5Y avg 18.8x · 30th percentile · Below historical baseline · Data 2005–2026
Loading P/E history...
P/E Ratio Analysis
As of June 20, 2026, Spok Holdings, Inc. (SPOK) trades at a price-to-earnings ratio of 14.0x, with a stock price of $10.51 and trailing twelve-month earnings per share of $0.51.
The current P/E is 25% below its 5-year average of 18.8x. Over the past five years, SPOK's P/E has ranged from a low of 4.4x to a high of 38.5x, placing the current valuation at the 30th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, SPOK trades at a 37% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, SPOK trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SPOK DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SPOK Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
SPOK P/E vs Peers
Healthcare Communications, Workforce and Supply Chain peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $66B | 31.0 | 1.67 | +38% | |
| $260M | 184.0 | - | +105%Best | |
| $471B | 46.9 | - | +0% | |
| $35B | 13.6Lowest | 1.21Best | - |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
SPOK Historical P/E Data (2005–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $10.90 | $0.60 | 18.2x | +27% |
| FY2025 Q4 | Dec 31 2025 | $13.19 | $0.76 | 17.4x | +21% |
| FY2025 Q3 | - | $17.25 | $0.80 | 21.6x | +51% |
| FY2025 Q2 | Jun 30 2025 | $17.68 | $0.83 | 21.3x | +49% |
| FY2025 Q1 | Mar 31 2025 | $16.44 | $0.78 | 21.1x | +47% |
| FY2024 Q4 | - | $16.05 | $0.74 | 21.7x | +52% |
| FY2024 Q3 | Sep 30 2024 | $15.06 | $0.73 | 20.6x | +44% |
| FY2024 Q2 | Jun 30 2024 | $14.81 | $0.77 | 19.2x | +34% |
| FY2024 Q1 | Mar 31 2024 | $15.95 | $0.83 | 19.2x | +34% |
| FY2023 Q4 | Dec 31 2023 | $15.48 | $0.77 | 20.1x | +41% |
| FY2023 Q3 | Sep 30 2023 | $14.27 | $1.81 | 7.9x | -45% |
| FY2023 Q2 | Jun 30 2023 | $13.29 | $1.74 | 7.6x | -47% |
| FY2023 Q1 | Mar 31 2023 | $10.13 | $1.61 | 6.3x | -56% |
| FY2022 Q4 | Dec 31 2022 | $8.19 | $1.09 | 7.5x | -47% |
| FY2017 Q3 | Sep 30 2017 | $15.35 | $0.45 | 34.1x | +139% |
| FY2017 Q2 | Jun 30 2017 | $17.70 | $0.46 | 38.5x | +169% |
| FY2017 Q1 | Mar 31 2017 | $19.00 | $0.56 | 33.9x | +137% |
| FY2016 Q4 | Dec 31 2016 | $20.75 | $0.69 | 30.1x | +110% |
| FY2016 Q3 | Sep 30 2016 | $17.82 | $4.07 | 4.4x | -69% |
| FY2016 Q2 | - | $19.17 | $4.07 | 4.7x | -67% |
| FY2016 Q1 | - | $17.51 | $4.06 | 4.3x | -70% |
| FY2015 Q4 | - | $18.32 | $4.07 | 4.5x | -69% |
| FY2015 Q3 | Sep 30 2015 | $16.46 | $0.85 | 19.4x | +35% |
| FY2015 Q2 | - | $16.84 | $0.86 | 19.6x | +37% |
| FY2015 Q1 | - | $19.17 | $0.89 | 21.5x | +51% |
| FY2014 Q4 | Dec 31 2014 | $17.36 | $0.93 | 18.7x | +31% |
| FY2014 Q3 | - | $13.01 | $0.98 | 13.3x | -7% |
| FY2014 Q2 | Jun 30 2014 | $15.40 | $1.03 | 15.0x | +5% |
| FY2014 Q1 | Mar 31 2014 | $18.17 | $1.15 | 15.8x | +10% |
| FY2013 Q4 | - | $14.28 | $1.25 | 11.4x | -20% |
| FY2013 Q3 | Sep 30 2013 | $14.16 | $0.98 | 14.4x | +1% |
| FY2013 Q2 | Jun 30 2013 | $13.57 | $1.08 | 12.5x | -12% |
| FY2013 Q1 | Mar 31 2013 | $13.27 | $1.14 | 11.6x | -19% |
| FY2012 Q4 | Dec 31 2012 | $11.68 | $1.19 | 9.8x | -32% |
| FY2012 Q3 | Sep 30 2012 | $11.87 | $1.96 | 6.1x | -58% |
| FY2012 Q2 | Jun 30 2012 | $12.86 | $2.06 | 6.2x | -56% |
| FY2012 Q1 | Mar 31 2012 | $13.93 | $2.51 | 5.5x | -61% |
| FY2011 Q4 | Dec 31 2011 | $13.87 | $3.96 | 3.5x | -76% |
| FY2011 Q3 | Sep 30 2011 | $13.20 | $4.94 | 2.7x | -81% |
| FY2011 Q2 | - | $15.26 | $5.17 | 3.0x | -79% |
| FY2011 Q1 | - | $14.48 | $4.93 | 2.9x | -79% |
| FY2010 Q4 | Dec 31 2010 | $17.77 | $3.50 | 5.1x | -64% |
| FY2010 Q3 | - | $16.03 | $1.82 | 8.8x | -38% |
| FY2010 Q2 | Jun 30 2010 | $12.92 | $1.53 | 8.4x | -41% |
| FY2010 Q1 | Mar 31 2010 | $12.67 | $2.88 | 4.4x | -69% |
| FY2009 Q4 | - | $11.01 | $2.92 | 3.8x | -74% |
| FY2009 Q3 | Sep 30 2009 | $12.88 | $3.11 | 4.1x | -71% |
| FY2009 Q2 | - | $12.76 | $2.80 | 4.6x | -68% |
| FY2009 Q1 | - | $9.21 | $1.24 | 7.4x | -48% |
| FY2007 Q3 | Sep 30 2007 | $16.87 | $1.98 | 8.5x | -40% |
| FY2007 Q2 | Jun 30 2007 | $26.76 | $1.55 | 17.3x | +21% |
| FY2007 Q1 | Mar 31 2007 | $19.93 | $1.48 | 13.5x | -6% |
| FY2006 Q4 | Dec 31 2006 | $22.37 | $1.46 | 15.3x | +7% |
| FY2006 Q3 | Sep 30 2006 | $22.84 | $1.67 | 13.7x | -4% |
| FY2006 Q2 | Jun 30 2006 | $16.60 | $1.37 | 12.1x | -15% |
| FY2006 Q1 | Mar 31 2006 | $28.48 | $0.88 | 32.5x | +127% |
| FY2005 Q4 | Dec 31 2005 | $27.72 | $0.47 | 58.6x | +310% |
Average P/E for displayed period: 14.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SPOK — Frequently Asked Questions
Quick answers to the most common questions about buying SPOK stock.
What is SPOK's P/E ratio?
Spok Holdings, Inc. (SPOK) trailing twelve-month P/E ratio is 14.0x, based on TTM diluted EPS of $0.51. The 5-year average P/E is 18.8x and the historical range spans 4.4x to 38.5x.
Is SPOK stock overvalued or undervalued?
SPOK trades at 14.0x P/E, below its 5-year average of 18.8x. At the 30th percentile of its historical range (4.4x–38.5x), the stock is priced at a discount to its own history.
Is SPOK stock expensive?
No, SPOK is not expensive on a historical basis. The current P/E of 14.0x is below the 5-year average of 18.8x and sits at the 30th percentile of its valuation range.
What is SPOK's historical P/E range?
Over the past 5 years, SPOK's P/E ratio has ranged from 4.4x to 38.5x, with a median of 20.1x and an average of 18.8x. The current P/E of 14.0x places the stock at the 30th percentile of this range. Full historical data spans 2005–2026.
How does SPOK's P/E compare to the S&P 500?
SPOK trades at 14.0x P/E versus the S&P 500 median of 24.4x. The 43% discount to the market suggests lower growth expectations or perceived higher risk.
How does SPOK's valuation compare to Healthcare peers?
Spok Holdings, Inc. P/E of 14.0x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is SPOK's PEG ratio?
SPOK PEG ratio is N/A, based on a P/E of 14.0x and EPS growth of 2.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is SPOK's earnings yield?
SPOK earnings yield is 7.14%, the inverse of its 14.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.